Email not displaying properly? View email in your browser
Vertical-Talk Pharma    Programmable Nanodevices
 First-Line Treatment for SAA
 Beta Cell Proliferation
Jan 2019   e-Newsletter Media Pack    |    Advertise
Follow Us Facebook Twitter Google Plus Linkedin
Turkish Cargo
News
Luye Pharma Reaches Strategic Partnership...
Phoenix Molecular Designs Announces Collaboration...
Kyn Therapeutics Enters into Global Strategic...
 
Press Releases
Sandoz and Pear Therapeutics Announce...
Menlo Therapeutics Serlopitant Granted...
Boehringer Ingelheim Biopharmaceuticals China...
 
Events
28 -28 Jan 2019
Pharma And Biotech IP
04 -07 Feb 2019
MEDLAB 2019
12 -14 Feb 2019
9th Annual Vaccine World Summit 2019
Articles
  Programmable Nanodevices for Biomedical Application
Chandan Adhikari, Asst Professor, Lovely Professional University, India
In 1960 a science fiction picture named ‘Fantastic Voyage’ was released with the storyline that A Nano-submarine was containing a group of scientists traveling through the bloodletting inside the body of a scientist to prevent his brain tumor. . Almost sixty years later we are very...
Pharmaceutical Compliance Congress Asia
Techno Trends
  Novartis Promacta® Approved as First-Line Treatment for Severe...
  Mount Sinai Researchers Determine Significant Beta Cell...
ACG-Myanmar-Pharma-Engineering
Projects
  Merck KGaA Inaugurates New Packaging Center in Darmstadt...
  Catalent Announces Completion of First Phase of US$7.3 Million...
Qatar Cargo
e-Magazine  |  Subscribe  |  Unsubscribe  |  Previous Issues  |  Advisory Board  |  Editorial Calendar  |  Archives
www.pharmafocusasia.com - Owned by Ochre Media Pvt. Ltd.
Tel: +91 40 4961 4567 | Fax: +91 40 4961 4555